Diabetes

Dapagliflozin improves glucose outcomes in type 1 diabetes

(HealthDay)—In patients with type 1 diabetes, treatment with dapagliflozin for 24 weeks improves time in range, mean glucose, and glycemic variability, according to a study published online April 9 in Diabetes Care.

Medical research

New discovery could lead to improved blood sugar level control

Many diabetes patients do not only have problems with their insulin, but also with the release of the hormone glucagon. Researchers at Uppsala University have now discovered a regulation mechanism which could provide an opportunity ...

Diabetes

Most diabetes phone apps lack education, support functions

(HealthDay)—Most diabetes apps miss opportunities to improve care and health outcomes by not providing real-time decision support or situation-specific education on blood glucose self-management, according to a research ...

Medications

FDA warns against use of preowned or unauthorized test strips

(HealthDay)—The U.S. Food and Drug Administration is warning patients not to use preowned test strips or test strips not authorized for sale in the United States because of possible infection or inaccurate results that ...

page 2 from 23